Qiagen to Transfer Transplant Dx Rights to Olerup | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen today said that it will transfer distribution rights for the Olerup line of molecular transplantation testing products to LinkMed subsidiary Olerup International on July 1.

The testing products included in the agreement are used for DNA HLA typing. The transfer of assets will include all Olerup SSP HLA sales infrastructure and offices in Austria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."